Agenus (Germany) Profile

EUR 0.01  0.55%

Agenus Summary

Agenus (AJ81) is traded on Frankfurt Stock Exchange in Germany. It is located in 3 Forbes Road and employs 255 people. The company currently falls under 'Small-Cap' category with current market capitalization of 219 M. Agenus has 99.6 M outstanding shares. AGENUS has accumulated about 52.35 M in cash with (119.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5.
Check Agenus Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 1.81HorizonTargetOdds Above 1.81
9.43%30 days 1.81 90.49%
Based on normal probability distribution, the odds of Agenus to move above current price in 30 days from now is about 90.49% (This Agenus probability density function shows the probability of Agenus Stock to fall within a particular range of prices over 30 days) .

Agenus Risk Profiles

Key Fundamentals

Agenus Against Markets

Current Ratings

Agenus 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Agenus are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the bodys immune system to fight cancer. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts. Agenus operates under Biotechnology classification in Germany and traded on Frankfurt Stock Exchange. It employs 255 people. more
Chairman of the Board, CEOGaro ArmenView All
Macroaxis Advice
InstrumentGermany Stock View All
Business Address3 Forbes Road
ExchangeFrankfurt Stock Exchange
Phone781 674 4400
CurrencyEUR - Euro

Agenus Corporate Directors

Ulf Wiinberg Director
Shalini Sharp Director
Wadih Jordan Independent Director
Check also Trending Equities. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.